We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$2.07B
AUM Growth
+$361M
Cap. Flow
+$391M
Cap. Flow %
18.88%
Top 10 Hldgs %
46.93%
Holding
58
New
10
Increased
9
Reduced
12
Closed
10

Top Buys

Rank Stock Value
1
ENDP
Endo International plc
ENDP
+$105M
2
GILD icon
Gilead Sciences
GILD
+$66.6M
3
CI icon
Cigna
CI
+$66M
4
CSII
Cardiovascular Systems, Inc.
CSII
+$64M
5
PRGO icon
Perrigo
PRGO
+$59M

Top Sells

Rank Stock Value
1
STJ
St Jude Medical
STJ
+$68.8M
2
ABBV icon
AbbVie
ABBV
+$51.4M
3
DGX icon
Quest Diagnostics
DGX
+$42.9M
4
MASI
Masimo
MASI
+$41.8M
5
NUVA
NuVasive, Inc.
NUVA
+$40.5M

Sector Composition

Rank Sector Weight
1 Healthcare 64.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNIS
51
DELISTED
Unilife Corporation
UNIS
– –
-275,000
Closed -$1.87M
MDVN
52
DELISTED
MEDIVATION, INC.
MDVN
– –
-825,000
Closed -$37.9M
1 2
3

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Camber Capital Management held 58 positions worth $2.07B, up 21% from $1.71B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Camber Capital Management deployed $391M of net new capital in Q2 2016, opening 10 new positions and adding to 9 existing holdings. Its largest new stake was Endo International plc: 5,045,000 shares worth $78.7M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, down from 69% a quarter earlier.

On the sell side, the largest reduction was NuVasive, Inc., an estimated $40.5M trimmed.

  • Camber Capital Management's largest Q2 2016 buy was Endo International plc: 5,045,000 shares worth $78.7M.
  • Camber Capital Management added most to Viatris in Q2 2016, an estimated $39.4M increase.
  • Camber Capital Management's biggest Q2 2016 reduction was NuVasive, Inc., cutting an estimated $40.5M.
  • Camber Capital Management fully exited St Jude Medical in Q2 2016, selling an estimated $68.8M.
  • Camber Capital Management's ten largest holdings make up 47% of its $2.07B portfolio in Q2 2016.
  • Camber Capital Management opened 10 new positions and closed 10 in Q2 2016.
  • Camber Capital Management's portfolio value rose 21% quarter-over-quarter to $2.07B.

Based on Camber Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.